Limited evidence for use of a black race modifier in eGFR calculations: a s ystematic review
Author
Marzinke, Mark AGreene, Dina N
Bossuyt, Patrick M
Chambliss, Allison B
Cirrincione, Lauren R
McCudden, Christopher R
Melanson, Stacy E F
Noguez, Jaime H
Patel, Khushbu
Radix, Asa E
Takwoingi, Yemisi
Winston-McPherson, Gabrielle
Young, Bessie A
Hoenig, Melanie P
Publication date
2022-03-31Subject
Clinical pathology
Metadata
Show full item recordAbstract
Background: Commonly used estimated glomerular filtration rate (eGFR) equations include a Black race modifier (BRM) that was incorporated during equation derivation. Race is a social construct, and a poorly characterized variable that is applied inconsistently in clinical settings. The BRM results in higher eGFR for any creatinine concentration, implying fundamental differences in creatinine production or excretion in Black individuals compared to other populations. Equations without inclusion of the BRM have the potential to detect kidney disease earlier in patients at the greatest risk of chronic kidney disease (CKD), but also has the potential to over-diagnose CKD or impact downstream clinical interventions. The purpose of this study was to use an evidence-based approach to systematically evaluate the literature relevant to the performance of the eGFR equations with and without the BRM and to examine the clinical impact of the use or removal. Content: PubMed and Embase databases were searched for studies comparing measured GFR to eGFR in racially diverse adult populations using the Modification of Diet in Renal Disease or the 2009-Chronic Kidney Disease Epidemiology Collaboration-creatinine equations based on standardized creatinine measurements. Additionally, we searched for studies comparing clinical use of eGFR calculated with and without the BRM. Here, 8632 unique publications were identified; an additional 3 studies were added post hoc. In total, 96 studies were subjected to further analysis and 44 studies were used to make a final assessment. Summary: There is limited published evidence to support the use of a BRM in eGFR equations.Citation
Marzinke MA, Greene DN, Bossuyt PM, Chambliss AB, Cirrincione LR, McCudden CR, Melanson SEF, Noguez JH, Patel K, Radix AE, Takwoingi Y, Winston-McPherson G, Young BA, Hoenig MP. Limited Evidence for Use of a Black Race Modifier in eGFR Calculations: A Systematic Review. Clin Chem. 2022 Mar 31;68(4):521-533. doi: 10.1093/clinchem/hvab279Type
ArticleOther
Additional Links
https://academic.oup.com/clinchemPMID
34927677Journal
Clinical ChemistryPublisher
Oxford University Pressae974a485f413a2113503eed53cd6c53
10.1093/clinchem/hvab279